mdma therapy

FDA Denies the Lykos Therapeutics Application for MDMA-Assisted Therapy
Lykos Responds to Opposition by FDA Advisors to MDMA-Assisted Therapy
How MAPS PBC Became Lykos Therapeutics and Raised $100M
Shifting Strategy, MAPS Turns to Equity Investment
Is the High Cost of Psychedelic Therapy Worth It?